Lantern Pharma Inc. (LTRN) › Cash & EquivalentsLantern Pharma Inc. (LTRN) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2018-12-31: $445.2K2019-12-31: $1.23M2020-12-31: $19.23M2021-12-31: $51.52M2022-12-31: $37.20M2023-12-31: $21.94M2024-12-31: $7.51M2025-12-31: $4.42M$4.42M2018-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$4.42M-41.1%2026-03-30Balance as of period end2024-12-31$7.51M-65.8%2026-03-30Balance as of period end2023-12-31$21.94M-41.0%2025-03-27Balance as of period end2022-12-31$37.20M-27.8%2024-03-18Balance as of period end2021-12-31$51.52M+167.9%2023-03-20Balance as of period end2020-12-31$19.23M+1460.8%2022-03-10Balance as of period end2019-12-31$1.23M+176.8%2021-03-10Balance as of period end2018-12-31$445.2K—2021-03-10Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)